Table 6.
The comparison of eicosanoids level between patients with low (<14) vs. higher (>13) BDI-II score.
| Eicosanoids [µg/mL] | Mean ± SD in Patients with Lower BDI-II Score n = 55 | Mean ± SD in Patients with higher BDI-II Score n = 19 | p-Value |
|---|---|---|---|
| Resolvin E1 | 0.054 ± 0.088 | 0.070 ± 0.099 | 0.504 |
| Prostaglandin E2 | 3.319 ± 3.14 | 3.185 ± 6.508 | 0.906 |
| Resolvin D1 | 0.174 ± 0.267 | 0.171 ± 0.22 | 0.969 |
| Lipoxin A4 LxA4 5S, 6R | 0.023 ± 0.171 | 0.00 | 0.56 |
| Lipoxin A4 15-epi-LxA4 A4 5S, 6R, 15R | 0.018 ± 0.037 | 0.036 ± 0.053 | 0.109 |
| Protectin D1 | 0.045 ± 0.053 | 0.053 ± 0.09 | 0.629 |
| Maresin 1 | 0.031 ± 0.016 | 0.030 ± 0.016 | 0.717 |
| Leukotriene B4 | 0.025 ± 0.014 | 0.029 ± 0.014 | 0.323 |
| 18RS HEPE | 0.111 ± 0.038 | 0.104 ± 0.035 | 0.490 |
| 16RS HETE | 0.014 ± 0.078 | 0.00 | 0.447 |
| 13S HODE | 0.032 ± 0.031 | 0.033 ± 0.025 | 0.856 |
| 9S HODE | 0.034 ± 0.03 | 0.03 ± 0.02 | 0.641 |
| 15S HETE | 0.292 ± 0.217 | 0.294 ± 0.17 | 0.971 |
| 17RS HDHA | 0.124 ± 0.092 | 0.118 ± 0.06 | 0.796 |
| 12S HETE | 1.787 ± 1.143 | 1.78 ± 1.121 | 0.98 |
| 5-oxo-ETE | 0.186 ± 0.103 | 0.187 ± 0.096 | 0.971 |
| 5 HETE | 0.025 ± 0.014 | 0.025 ± 0.011 | 0.996 |
* p < 0.05 statistically significant differences.